Clinical Trial Update: Administration of Kisspeptin in Patients With Hyperprolactinemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Kisspeptin in patients with hyperprolactinemia; the study status is completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperprolactinemia
• Hypogonadism

Drugs mentioned

• Kisspeptin (Kisspeptin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hyperprolactinemia, Hypogonadism | Phase 2 | Status: COMPLETED | Results posted: 2024-08-20